<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>21272504</identifier>
<setSpec>1087-2108</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Di Martino Ortiz, Beatriz</dc:author>
<dc:author>Masi, Mirtha Rodriguez</dc:author>
<dc:author>de Lezcano, Lourdes Bolla</dc:author>
<dc:author>Knopfelmacher, Oilda</dc:author>
<dc:description xml:lang="en">Childhood leprosy is very common, especially in tropical and subtropical areas, such as Paraguay. Early symptoms can be missed in a routine examination and the diagnosis can pass unnoticed. Pediatricians and dermatologists should remember the manifestations of this disease in order to make an early diagnosis. We present the case of a 10-year-old child with borderline Hansen disease, considered unusual in children. She was treated with multibacillary therapy (MB-WHO) with the combination of Rifampicin 600 mg, clofazimine 300 mg, and dapsone 100 mg once a month (the three drugs together on the same day once a month for 18 months); the remaining 28 days of the month, the child received clofazimine 50 mg/day and dapsone 100 mg/day (the two drugs together on the same day 28 days of the month for 18 months). This therapy produced complete remission of the lesions without reactional states.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>2011 Jan 15 </dc:date>
<dc:title xml:lang="es">Lepra infantil: Presentaci√≥n de un caso.</dc:title>
<dc:title xml:lang="en">[Childhood leprosy: Report of a case].</dc:title>
<dc:publisher>Dermatology online journal</dc:publisher>
</metadata>
</record>
</pubmed-document>
